APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Mono Hepatitis Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Mono Hepatitis Vaccine Industry Growth and Trends Forecast to 2032

Report ID 17401407012 January 2026103 pages

Choose your research edition.

Industry ResearchMono Hepatitis Vaccine Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Mono Hepatitis Vaccine Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Mono Hepatitis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mono Hepatitis Vaccine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Mono Hepatitis Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Mono Hepatitis Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Mono Hepatitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Mono Hepatitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mono Hepatitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mono Hepatitis Vaccine include Sanofi, Merck, GSK, Zhejiang Pukang, Sinovac, Serum Institute, NCPC, LG Life Sciences and KM Biologics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Mono Hepatitis Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Mono Hepatitis Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Mono Hepatitis Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Mono Hepatitis Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Mono Hepatitis Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Mono Hepatitis Vaccine Market by Company

Sanofi

Merck

GSK

Zhejiang Pukang

Sinovac

Serum Institute

NCPC

LG Life Sciences

KM Biologics

IMBCA

Hissen

Dynavax

ChangSheng

Bio Kangtai

Mono Hepatitis Vaccine Segment by Type

Hepatitis A Vaccines

Hepatitis B Vaccines

Mono Hepatitis Vaccine Segment by Application

Children

Adult

Mono Hepatitis Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mono Hepatitis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mono Hepatitis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mono Hepatitis Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Mono Hepatitis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Mono Hepatitis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Hepatitis A Vaccines Table 2. Major Company of Hepatitis B Vaccines Table 3. Global Mono Hepatitis Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Mono Hepatitis Vaccine Sales by Type (2021-2026) & (K Units) Table 5. Global Mono Hepatitis Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Mono Hepatitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Mono Hepatitis Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Mono Hepatitis Vaccine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Mono Hepatitis Vaccine Sales by Type (2027-2032) & (K Units) Table 10. Global Mono Hepatitis Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Mono Hepatitis Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Mono Hepatitis Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Mono Hepatitis Vaccine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Mono Hepatitis Vaccine Sales by Type (2021-2026) & (K Units) Table 15. North America Mono Hepatitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Mono Hepatitis Vaccine Sales by Type (2021-2026) & (K Units) Table 17. Europe Mono Hepatitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Mono Hepatitis Vaccine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Mono Hepatitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Mono Hepatitis Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Mono Hepatitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Mono Hepatitis Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Mono Hepatitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Mono Hepatitis Vaccine Industry Trends Table 25. Mono Hepatitis Vaccine Industry Drivers Table 26. Mono Hepatitis Vaccine Industry Opportunities and Challenges Table 27. Mono Hepatitis Vaccine Industry Restraints Table 28. Global Mono Hepatitis Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Mono Hepatitis Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Mono Hepatitis Vaccine Sales by Company (2021-2026) & (K Units) Table 31. Global Mono Hepatitis Vaccine Sales Share by Company (2021-2026) Table 32. Global Mono Hepatitis Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Mono Hepatitis Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Mono Hepatitis Vaccine Major Company Production Sites and Headquarters Table 35. Global Mono Hepatitis Vaccine Company, Product Type & Application Table 36. Global Mono Hepatitis Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Mono Hepatitis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Mono Hepatitis Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Mono Hepatitis Vaccine Sales by Region (2021-2026) & (K Units) Table 41. Global Mono Hepatitis Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Mono Hepatitis Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Mono Hepatitis Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Mono Hepatitis Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Mono Hepatitis Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global Mono Hepatitis Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Mono Hepatitis Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Mono Hepatitis Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Mono Hepatitis Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Mono Hepatitis Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Mono Hepatitis Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global Mono Hepatitis Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Mono Hepatitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Mono Hepatitis Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Mono Hepatitis Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Mono Hepatitis Vaccine Sales by Application (2027-2032) & (K Units) Table 57. Global Mono Hepatitis Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Mono Hepatitis Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Mono Hepatitis Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Mono Hepatitis Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Mono Hepatitis Vaccine Sales by Application (2021-2026) & (K Units) Table 62. North America Mono Hepatitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Mono Hepatitis Vaccine Sales by Application (2021-2026) & (K Units) Table 64. Europe Mono Hepatitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Mono Hepatitis Vaccine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Mono Hepatitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Mono Hepatitis Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Mono Hepatitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Mono Hepatitis Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Mono Hepatitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Sanofi Company Information Table 72. Sanofi Business Overview Table 73. Sanofi Mono Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Sanofi Mono Hepatitis Vaccine Product Portfolio Table 75. Sanofi Recent Development Table 76. Merck Company Information Table 77. Merck Business Overview Table 78. Merck Mono Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Merck Mono Hepatitis Vaccine Product Portfolio Table 80. Merck Recent Development Table 81. GSK Company Information Table 82. GSK Business Overview Table 83. GSK Mono Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. GSK Mono Hepatitis Vaccine Product Portfolio Table 85. GSK Recent Development Table 86. Zhejiang Pukang Company Information Table 87. Zhejiang Pukang Business Overview Table 88. Zhejiang Pukang Mono Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Zhejiang Pukang Mono Hepatitis Vaccine Product Portfolio Table 90. Zhejiang Pukang Recent Development Table 91. Sinovac Company Information Table 92. Sinovac Business Overview Table 93. Sinovac Mono Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Sinovac Mono Hepatitis Vaccine Product Portfolio Table 95. Sinovac Recent Development Table 96. Serum Institute Company Information Table 97. Serum Institute Business Overview Table 98. Serum Institute Mono Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Serum Institute Mono Hepatitis Vaccine Product Portfolio Table 100. Serum Institute Recent Development Table 101. NCPC Company Information Table 102. NCPC Business Overview Table 103. NCPC Mono Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. NCPC Mono Hepatitis Vaccine Product Portfolio Table 105. NCPC Recent Development Table 106. LG Life Sciences Company Information Table 107. LG Life Sciences Business Overview Table 108. LG Life Sciences Mono Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. LG Life Sciences Mono Hepatitis Vaccine Product Portfolio Table 110. LG Life Sciences Recent Development Table 111. KM Biologics Company Information Table 112. KM Biologics Business Overview Table 113. KM Biologics Mono Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. KM Biologics Mono Hepatitis Vaccine Product Portfolio Table 115. KM Biologics Recent Development Table 116. IMBCA Company Information Table 117. IMBCA Business Overview Table 118. IMBCA Mono Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. IMBCA Mono Hepatitis Vaccine Product Portfolio Table 120. IMBCA Recent Development Table 121. Hissen Company Information Table 122. Hissen Business Overview Table 123. Hissen Mono Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Hissen Mono Hepatitis Vaccine Product Portfolio Table 125. Hissen Recent Development Table 126. Dynavax Company Information Table 127. Dynavax Business Overview Table 128. Dynavax Mono Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Dynavax Mono Hepatitis Vaccine Product Portfolio Table 130. Dynavax Recent Development Table 131. ChangSheng Company Information Table 132. ChangSheng Business Overview Table 133. ChangSheng Mono Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. ChangSheng Mono Hepatitis Vaccine Product Portfolio Table 135. ChangSheng Recent Development Table 136. Bio Kangtai Company Information Table 137. Bio Kangtai Business Overview Table 138. Bio Kangtai Mono Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Bio Kangtai Mono Hepatitis Vaccine Product Portfolio Table 140. Bio Kangtai Recent Development Table 141. North America Mono Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. North America Mono Hepatitis Vaccine Sales by Country (2021-2026) & (K Units) Table 143. North America Mono Hepatitis Vaccine Sales Market Share by Country (2021-2026) Table 144. North America Mono Hepatitis Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 145. North America Mono Hepatitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 146. North America Mono Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Mono Hepatitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Mono Hepatitis Vaccine Market Share by Country (2021-2026) Table 149. North America Mono Hepatitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Mono Hepatitis Vaccine Market Share Forecast by Country (2027-2032) Table 151. Europe Mono Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Europe Mono Hepatitis Vaccine Sales by Country (2021-2026) & (K Units) Table 153. Europe Mono Hepatitis Vaccine Sales Market Share by Country (2021-2026) Table 154. Europe Mono Hepatitis Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 155. Europe Mono Hepatitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Mono Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Mono Hepatitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Mono Hepatitis Vaccine Market Share by Country (2021-2026) Table 159. Europe Mono Hepatitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Mono Hepatitis Vaccine Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Mono Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Mono Hepatitis Vaccine Sales by Country (2021-2026) & (K Units) Table 163. Asia-Pacific Mono Hepatitis Vaccine Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Mono Hepatitis Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 165. Asia-Pacific Mono Hepatitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Mono Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Mono Hepatitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Mono Hepatitis Vaccine Market Share by Country (2021-2026) Table 169. Asia-Pacific Mono Hepatitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Mono Hepatitis Vaccine Market Share Forecast by Country (2027-2032) Table 171. Latin America Mono Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Latin America Mono Hepatitis Vaccine Sales by Country (2021-2026) & (K Units) Table 173. Latin America Mono Hepatitis Vaccine Sales Market Share by Country (2021-2026) Table 174. Latin America Mono Hepatitis Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 175. Latin America Mono Hepatitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Mono Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Mono Hepatitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Mono Hepatitis Vaccine Market Share by Country (2021-2026) Table 179. Latin America Mono Hepatitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Mono Hepatitis Vaccine Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Mono Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Mono Hepatitis Vaccine Sales by Country (2021-2026) & (K Units) Table 183. Middle East and Africa Mono Hepatitis Vaccine Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Mono Hepatitis Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 185. Middle East and Africa Mono Hepatitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Mono Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Mono Hepatitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Mono Hepatitis Vaccine Market Share by Country (2021-2026) Table 189. Middle East and Africa Mono Hepatitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Mono Hepatitis Vaccine Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Mono Hepatitis Vaccine Distributors List Table 194. Mono Hepatitis Vaccine Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Mono Hepatitis Vaccine Image Figure 2. Global Mono Hepatitis Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mono Hepatitis Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Mono Hepatitis Vaccine Sales (2021-2032) & (K Units) Figure 5. Hepatitis A Vaccines Image Figure 6. Global Hepatitis A Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 7. Hepatitis B Vaccines Image Figure 8. Global Hepatitis B Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Mono Hepatitis Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Mono Hepatitis Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Mono Hepatitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Mono Hepatitis Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Mono Hepatitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Mono Hepatitis Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Mono Hepatitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Mono Hepatitis Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Mono Hepatitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Mono Hepatitis Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Mono Hepatitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Mono Hepatitis Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Mono Hepatitis Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Children Image Figure 24. Global Children Sales YoY Growth (2021-2032) & (K Units) Figure 25. Adult Image Figure 26. Global Adult Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Mono Hepatitis Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Mono Hepatitis Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Mono Hepatitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Mono Hepatitis Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Mono Hepatitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Mono Hepatitis Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Mono Hepatitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Mono Hepatitis Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Mono Hepatitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Mono Hepatitis Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Mono Hepatitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Mono Hepatitis Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Mono Hepatitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Mono Hepatitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Mono Hepatitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Mono Hepatitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Mono Hepatitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Mono Hepatitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Mono Hepatitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Mono Hepatitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Mono Hepatitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Mono Hepatitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Mono Hepatitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Mono Hepatitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Mono Hepatitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Mono Hepatitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Mono Hepatitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Mono Hepatitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Mono Hepatitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Mono Hepatitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Mono Hepatitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Mono Hepatitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Mono Hepatitis Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Mono Hepatitis Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Hepatitis A Vaccines
  • Hepatitis B Vaccines
Applications
  • Children
  • Adult
Companies covered
  • Sanofi
  • Merck
  • GSK
  • Zhejiang Pukang
  • Sinovac
  • Serum Institute
  • NCPC
  • LG Life Sciences
  • KM Biologics
  • IMBCA
  • Hissen
  • Dynavax
  • ChangSheng
  • Bio Kangtai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mono Hepatitis Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Mono Hepatitis Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Mono Hepatitis Vaccine Market by Type
  6. 1.3.1 Hepatitis A Vaccines
  7. 1.3.2 Hepatitis B Vaccines
  8. 1.4 Global Mono Hepatitis Vaccine Market Size by Type
  9. 1.4.1 Global Mono Hepatitis Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Mono Hepatitis Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Mono Hepatitis Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Mono Hepatitis Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Mono Hepatitis Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Mono Hepatitis Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Mono Hepatitis Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Mono Hepatitis Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Mono Hepatitis Vaccine Industry Trends
  2. 2.2 Mono Hepatitis Vaccine Industry Drivers
  3. 2.3 Mono Hepatitis Vaccine Industry Opportunities and Challenges
  4. 2.4 Mono Hepatitis Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Mono Hepatitis Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Mono Hepatitis Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Mono Hepatitis Vaccine Price (2021-2026)
  4. 3.4 Global Mono Hepatitis Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mono Hepatitis Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Mono Hepatitis Vaccine Company, Product Type & Application
  7. 3.7 Global Mono Hepatitis Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mono Hepatitis Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mono Hepatitis Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Mono Hepatitis Vaccine Tier 1, Tier 2, and Tier 3
4 Mono Hepatitis Vaccine Regional Status and Outlook
  1. 4.1 Global Mono Hepatitis Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Mono Hepatitis Vaccine Historic Market Size by Region
  3. 4.2.1 Global Mono Hepatitis Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Mono Hepatitis Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Mono Hepatitis Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Mono Hepatitis Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Mono Hepatitis Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Mono Hepatitis Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Mono Hepatitis Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Mono Hepatitis Vaccine by Application
  1. 5.1 Mono Hepatitis Vaccine Market by Application
  2. 5.1.1 Children
  3. 5.1.2 Adult
  4. 5.2 Global Mono Hepatitis Vaccine Market Size by Application
  5. 5.2.1 Global Mono Hepatitis Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Mono Hepatitis Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Mono Hepatitis Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Mono Hepatitis Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Mono Hepatitis Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Mono Hepatitis Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Mono Hepatitis Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Mono Hepatitis Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Mono Hepatitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Mono Hepatitis Vaccine Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Mono Hepatitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Mono Hepatitis Vaccine Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 GSK
  14. 6.3.1 GSK Company Information
  15. 6.3.2 GSK Business Overview
  16. 6.3.3 GSK Mono Hepatitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GSK Mono Hepatitis Vaccine Product Portfolio
  18. 6.3.5 GSK Recent Developments
  19. 6.4 Zhejiang Pukang
  20. 6.4.1 Zhejiang Pukang Company Information
  21. 6.4.2 Zhejiang Pukang Business Overview
  22. 6.4.3 Zhejiang Pukang Mono Hepatitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Zhejiang Pukang Mono Hepatitis Vaccine Product Portfolio
  24. 6.4.5 Zhejiang Pukang Recent Developments
  25. 6.5 Sinovac
  26. 6.5.1 Sinovac Company Information
  27. 6.5.2 Sinovac Business Overview
  28. 6.5.3 Sinovac Mono Hepatitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sinovac Mono Hepatitis Vaccine Product Portfolio
  30. 6.5.5 Sinovac Recent Developments
  31. 6.6 Serum Institute
  32. 6.6.1 Serum Institute Company Information
  33. 6.6.2 Serum Institute Business Overview
  34. 6.6.3 Serum Institute Mono Hepatitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Serum Institute Mono Hepatitis Vaccine Product Portfolio
  36. 6.6.5 Serum Institute Recent Developments
  37. 6.7 NCPC
  38. 6.7.1 NCPC Company Information
  39. 6.7.2 NCPC Business Overview
  40. 6.7.3 NCPC Mono Hepatitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 NCPC Mono Hepatitis Vaccine Product Portfolio
  42. 6.7.5 NCPC Recent Developments
  43. 6.8 LG Life Sciences
  44. 6.8.1 LG Life Sciences Company Information
  45. 6.8.2 LG Life Sciences Business Overview
  46. 6.8.3 LG Life Sciences Mono Hepatitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 LG Life Sciences Mono Hepatitis Vaccine Product Portfolio
  48. 6.8.5 LG Life Sciences Recent Developments
  49. 6.9 KM Biologics
  50. 6.9.1 KM Biologics Company Information
  51. 6.9.2 KM Biologics Business Overview
  52. 6.9.3 KM Biologics Mono Hepatitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 KM Biologics Mono Hepatitis Vaccine Product Portfolio
  54. 6.9.5 KM Biologics Recent Developments
  55. 6.10 IMBCA
  56. 6.10.1 IMBCA Company Information
  57. 6.10.2 IMBCA Business Overview
  58. 6.10.3 IMBCA Mono Hepatitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 IMBCA Mono Hepatitis Vaccine Product Portfolio
  60. 6.10.5 IMBCA Recent Developments
  61. 6.11 Hissen
  62. 6.11.1 Hissen Company Information
  63. 6.11.2 Hissen Business Overview
  64. 6.11.3 Hissen Mono Hepatitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Hissen Mono Hepatitis Vaccine Product Portfolio
  66. 6.11.5 Hissen Recent Developments
  67. 6.12 Dynavax
  68. 6.12.1 Dynavax Company Information
  69. 6.12.2 Dynavax Business Overview
  70. 6.12.3 Dynavax Mono Hepatitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Dynavax Mono Hepatitis Vaccine Product Portfolio
  72. 6.12.5 Dynavax Recent Developments
  73. 6.13 ChangSheng
  74. 6.13.1 ChangSheng Company Information
  75. 6.13.2 ChangSheng Business Overview
  76. 6.13.3 ChangSheng Mono Hepatitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 ChangSheng Mono Hepatitis Vaccine Product Portfolio
  78. 6.13.5 ChangSheng Recent Developments
  79. 6.14 Bio Kangtai
  80. 6.14.1 Bio Kangtai Company Information
  81. 6.14.2 Bio Kangtai Business Overview
  82. 6.14.3 Bio Kangtai Mono Hepatitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Bio Kangtai Mono Hepatitis Vaccine Product Portfolio
  84. 6.14.5 Bio Kangtai Recent Developments
7 North America by Country
  1. 7.1 North America Mono Hepatitis Vaccine Sales by Country
  2. 7.1.1 North America Mono Hepatitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Mono Hepatitis Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Mono Hepatitis Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Mono Hepatitis Vaccine Market Size by Country
  6. 7.2.1 North America Mono Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Mono Hepatitis Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Mono Hepatitis Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Mono Hepatitis Vaccine Sales by Country
  2. 8.1.1 Europe Mono Hepatitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Mono Hepatitis Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Mono Hepatitis Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Mono Hepatitis Vaccine Market Size by Country
  6. 8.2.1 Europe Mono Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Mono Hepatitis Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Mono Hepatitis Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Mono Hepatitis Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Mono Hepatitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Mono Hepatitis Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Mono Hepatitis Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Mono Hepatitis Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Mono Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Mono Hepatitis Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Mono Hepatitis Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Mono Hepatitis Vaccine Sales by Country
  2. 10.1.1 South America Mono Hepatitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Mono Hepatitis Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Mono Hepatitis Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Mono Hepatitis Vaccine Market Size by Country
  6. 10.2.1 South America Mono Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Mono Hepatitis Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Mono Hepatitis Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Mono Hepatitis Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Mono Hepatitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Mono Hepatitis Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Mono Hepatitis Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Mono Hepatitis Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Mono Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Mono Hepatitis Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Mono Hepatitis Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Mono Hepatitis Vaccine Value Chain Analysis
  2. 12.1.1 Mono Hepatitis Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Mono Hepatitis Vaccine Production Mode & Process
  7. 12.2 Mono Hepatitis Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Mono Hepatitis Vaccine Distributors
  10. 12.2.3 Mono Hepatitis Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst